Study aims to perfect drug combo for Kids' airway management

NCT ID NCT07581665

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests different doses of alfentanil (a painkiller) combined with propofol (a sleep medicine) to find the best amount for placing a laryngeal mask airway in children aged 7 to 12. The goal is to make the procedure smoother and safer. Forty children having day surgery will take part, and the dose will be adjusted based on how well each child responds.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

alfentanil and propofol

What this could lead to

If successful, this could help anesthesiologists use the safest, most effective doses of these drugs for children, reducing complications during surgery.

What could go wrong

This is a small, early-phase study with only 40 children, so results may not apply to all kids or settings. The drugs can cause side effects like breathing problems or low blood pressure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AIRWAY MANAGEMENT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Anesthesiology, Zhongshan Ophthalmic Center, Sun Yat-sen University

    Guangzhou, Guangdong, 510000, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••